Supernus Pharmaceuticals (SUPN) News Today $45.46 -1.20 (-2.57%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$45.47 +0.01 (+0.02%) As of 09/12/2025 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SUPN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Villanova Investment Management Co LLC Has $641,000 Stock Position in Supernus Pharmaceuticals, Inc. $SUPNSeptember 13 at 6:33 AM | marketbeat.comSupernus Pharmaceuticals, Inc. $SUPN Shares Sold by Great Lakes Advisors LLCSeptember 12 at 5:37 AM | marketbeat.comSupernus Pharmaceuticals (NASDAQ:SUPN) CEO Sells $292,645.38 in StockSeptember 11 at 5:43 PM | marketbeat.comAxiom Investors LLC DE Sells 15,521 Shares of Supernus Pharmaceuticals, Inc. $SUPNSeptember 11 at 5:37 AM | marketbeat.comSupernus Pharmaceuticals (NASDAQ:SUPN) CEO Jack Khattar Sells 55,578 SharesSeptember 10 at 5:57 PM | marketbeat.comSupernus Pharmaceuticals (NASDAQ:SUPN) Hits New 52-Week High - Here's WhySeptember 10 at 12:16 PM | marketbeat.comCEO’s Major Stock Sale Shakes Up Supernus PharmaceuticalsSeptember 9, 2025 | tipranks.comCan Mixed Fundamentals Have A Negative Impact on Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Current Share Price Momentum?September 9, 2025 | finance.yahoo.comSupernus Pharmaceuticals (NASDAQ:SUPN) CEO Sells $2,557,143.78 in StockSeptember 9, 2025 | insidertrades.comUnpacking Q2 Earnings: Eli Lilly (NYSE:LLY) In The Context Of Other Branded Pharmaceuticals StocksSeptember 8, 2025 | finance.yahoo.comSupernus Pharmaceuticals, Inc. $SUPN Stock Position Cut by PDT Partners LLCSeptember 6, 2025 | marketbeat.comSupernus Pharmaceuticals, Inc. $SUPN Stock Position Raised by Cubist Systematic Strategies LLCSeptember 6, 2025 | marketbeat.comSupernus Pharmaceuticals (NASDAQ:SUPN) Hits New 52-Week High - What's Next?September 4, 2025 | marketbeat.comTrexquant Investment LP Has $4.73 Million Holdings in Supernus Pharmaceuticals, Inc. $SUPNSeptember 3, 2025 | marketbeat.comSupernus Pharmaceuticals, Inc. $SUPN Shares Purchased by Armistice Capital LLCSeptember 2, 2025 | marketbeat.comNorthern Trust Corp Cuts Stock Holdings in Supernus Pharmaceuticals, Inc. $SUPNSeptember 2, 2025 | marketbeat.com2 Healthcare Stocks on Our Watchlist and 1 We AvoidSeptember 1, 2025 | uk.finance.yahoo.comAshford Capital Management Inc. Purchases 20,781 Shares of Supernus Pharmaceuticals, Inc. $SUPNSeptember 1, 2025 | marketbeat.comPiper Sandler Raises Supernus Pharmaceuticals (NASDAQ:SUPN) Price Target to $40.00August 31, 2025 | marketbeat.comHsbc Holdings PLC Sells 180,627 Shares of Supernus Pharmaceuticals, Inc. $SUPNAugust 31, 2025 | marketbeat.comFrank Mottola At Supernus Pharmaceuticals Capitalizes: Options Exercised, Resulting In $448KAugust 30, 2025 | benzinga.comSupernus Pharmaceuticals, Inc. $SUPN Shares Sold by Epoch Investment Partners Inc.August 30, 2025 | marketbeat.comSupernus Pharmaceuticals CEO Makes Major Stock Sale!August 29, 2025 | tipranks.comNuveen LLC Buys Shares of 134,127 Supernus Pharmaceuticals, Inc. $SUPNAugust 29, 2025 | marketbeat.comSupernus Pharmaceuticals (NASDAQ:SUPN) CEO Sells $45,000.00 in StockAugust 28, 2025 | insidertrades.comSupernus Pharmaceuticals, Inc. $SUPN Position Reduced by Russell Investments Group Ltd.August 28, 2025 | marketbeat.comSupernus Pharmaceuticals to Participate in September Investor ConferencesAugust 27, 2025 | globenewswire.comSupernus Pharmaceuticals (NASDAQ:SUPN) Reaches New 12-Month High - What's Next?August 27, 2025 | marketbeat.comSupernus Pharmaceuticals, Inc. $SUPN Shares Sold by Axiom Investors LLC DEAugust 27, 2025 | marketbeat.comInsider Selling: Supernus Pharmaceuticals (NASDAQ:SUPN) CFO Sells 11,780 Shares of StockAugust 27, 2025 | insidertrades.comInsider Sell: NEWHALL CHARLES W III Sells Shares of Supernus Pharmaceuticals Inc (SUPN)August 26, 2025 | gurufocus.comSystematic Financial Management LP Buys 53,004 Shares of Supernus Pharmaceuticals, Inc. $SUPNAugust 26, 2025 | marketbeat.comCandriam S.C.A. Sells 48,363 Shares of Supernus Pharmaceuticals, Inc. $SUPNAugust 26, 2025 | marketbeat.com2 Safe-and-Steady Stocks to Target This Week and 1 We Brush OffAugust 25, 2025 | finance.yahoo.comMartingale Asset Management L P Raises Holdings in Supernus Pharmaceuticals, Inc. $SUPNAugust 25, 2025 | marketbeat.comDeutsche Bank AG Sells 58,766 Shares of Supernus Pharmaceuticals, Inc. $SUPNAugust 25, 2025 | marketbeat.comSupernus Pharmaceuticals, Inc. $SUPN Shares Bought by Invesco Ltd.August 24, 2025 | marketbeat.comSupernus Pharmaceuticals (NASDAQ:SUPN) Upgraded by Zacks Research to Hold RatingAugust 23, 2025 | marketbeat.comEntryPoint Capital LLC Buys New Shares in Supernus Pharmaceuticals, Inc. $SUPNAugust 23, 2025 | marketbeat.comSupernus Pharmaceuticals, Inc. $SUPN Holdings Lowered by Charles Schwab Investment Management Inc.August 23, 2025 | marketbeat.comVanguard Group Inc. Buys 13,133 Shares of Supernus Pharmaceuticals, Inc. $SUPNAugust 22, 2025 | marketbeat.com1 Small-Cap Stock with Competitive Advantages and 2 We Brush OffAugust 21, 2025 | msn.comBethany Sensenig Sells 5,369 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) StockAugust 20, 2025 | marketbeat.comSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Director Frederick M. Hudson Sells 7,457 SharesAugust 20, 2025 | marketbeat.comSupernus Pharmaceuticals (NASDAQ:SUPN) Sets New 1-Year High - Here's What HappenedAugust 20, 2025 | marketbeat.comInsider Decision: Frederick Hudson Offloads $315K Worth Of Supernus Pharmaceuticals StockAugust 20, 2025 | benzinga.comSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Director Sells $226,840.25 in StockAugust 19, 2025 | insidertrades.comInsider Sell: Bethany Sensenig Sells 5,369 Shares of Supernus Pharmaceuticals Inc (SUPN)August 18, 2025 | gurufocus.comWinners And Losers Of Q2: Zoetis (NYSE:ZTS) Vs The Rest Of The Branded Pharmaceuticals StocksAugust 18, 2025 | msn.comPublic Sector Pension Investment Board Purchases 82,167 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)August 16, 2025 | marketbeat.com Get Supernus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SUPN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SUPN Media Mentions By Week SUPN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SUPN News Sentiment▼0.690.92▲Average Medical News Sentiment SUPN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SUPN Articles This Week▼137▲SUPN Articles Average Week Get the Latest News and Ratings for SUPN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Supernus Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies JAZZ News CORT News PRGO News PCRX News NKTR News OMER News ASMB News CPIX News LLY News JNJ News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SUPN) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Supernus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Supernus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SUPN Stock Alerts